Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-17

Clinical Trial Update: Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating maintenance of treatment response in moderate plaque psoriasis with combination therapy of Olux E Foam (clobetasol propionate) and Sori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olux E Foam (clobetasol propionate)
  • Sorilux Foam (calcipotriene)

Snippet

Sponsor: Leon Kircik, M.D. | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2016-11-17